Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Savant HWP, Inc.

Latest From Savant HWP, Inc.

Best Of BIO: Policy & Regulatory Updates From BIO 2017

Antibiotic incentives, vaccine strategies, drug pricing, patent updates and more hot topics from the Biotechnology Innovation Organization's recent annual conference.

ImmunoOncology Market Access

Start-Up Previews, February 2013

This Month's Profile Group: Medtech Start-Ups Battle Advanced Skin Cancer With Innovative Technologies, features profiles of OncoSec, Sensus Healthcare, and Siva Therapeutics. Plus these Start-Ups Across Health Care: Avillion, CardioLogical Solutions, Fixes 4 Kids, RenovoRx, and Savant HWP.

BioPharmaceutical Medical Device

Savant HWP Inc.

The founders of Savant HWP Inc. believe they have identified a molecule that could prove effective in treating many kinds of substance as well as behavioral addictions, because it appears to influence relevant brain chemistry at a fundamental level. Its compound binds to the alpha-3-beta-4 nicotinic acetylcholine receptor and appears to indirectly regulate production of dopamine in the mid-brain.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Savant Neglected Diseases, LLC